MedPath
NMPA Approval

Dacomitinib Tablets

国药准字H20254222

May 20, 2025

Drug Information

达可替尼片

片剂

15mg

化学药品

May 20, 2025

Company Information

Applicant Company

成都高新区西源大道8号

Manufacturing Company

成都高新区西源大道8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达可替尼片 - NMPA 批准文号 | MedPath